Safety, Tolerability and Pharmacokinetics of NTP42:KVA4
Clinical trial NCT04919863 · COMPLETED
Trial details
- NCT number
- NCT04919863
- Sponsor
- ATXA Therapeutics Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-24
- Primary completion
- 2022-01-20
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.